Evidence map›Paper›PMID 22584729›Full record

ReviewJournal of assisted reproduction and genetics2012

Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances.

Gary Levy, Micah J Hill, Stephanie Beall, Shvetha M Zarek, James H Segars, William H Catherino

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of assisted reproduction and genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Uterine leiomyomas revisited with review of literature.Abdominal radiology (New York) · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Uterine Fibroids: Burden and Unmet Medical Need.Seminars in reproductive medicine · 2017
    Review
  16. Article
  17. Article
  18. Case series: Pregnancy Outcome in Patients with Uterine Fibroids.Journal of clinical and diagnostic research : JCDR · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gary LevyProgram in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, USA. gary.levy@nih.gov
Micah J Hill
Stephanie Beall
Shvetha M Zarek
James H Segars
William H Catherino
National Institutes of Health · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USUniformed Services University of the Health Sciences · US

Funding

Reproductive Endocrinology And Infertility Clinical Training ProgramZIEHD008737 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI HILL, MICAH · 2011 to 2025
$24.0M
6 · The paper itself

Abstract

purposeUterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged women. They are associated with gynecologic morbidity and detrimentally affect reproductive potential. The etiology of leiomyomas is poorly understood and their diagnosis prior to treatment with Assisted Reproductive Technologies (ART) represents a management dilemma. The purpose of this paper is to review known genetic and molecular contributions to the etiologies of leiomyomas, describe their impact on ART outcomes and reproductive potential, and review alternative therapies and future directions in management.

methodsA critical review of the literature pertaining to genetic component of uterine leiomyomas, their impact on ART and pregnancy and leiomyoma therapeutics was performed.

resultsUterine leiomyomas are characterized by complex molecular mechanisms. Their location and size determines their potential detriment to ART and reproductive function and novel therapeutic modalities are being developed.

conclusionThe high prevalence of uterine leiomyomas and their potential detrimental influence on ART and reproductive function warrants continued well-designed studies to ascertain their etiology, optimal treatment and novel less morbid therapies.

Indexed as

Reproductive Techniques, AssistedFemaleHumansInfant MortalityInfant, NewbornLeiomyomaPregnancyPregnancy Complications, NeoplasticPregnancy OutcomePrevalenceUterine MyomectomyUterine Neoplasms

Identifiers

PMID22584729
PMCPMC3430786
OpenAlexW2063224639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.